Note: Ingredients listed on restricted chemical lists
EC/CAS
216-823-5/1675-54-3
Name of the chemical
2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
Concentration
≥50
EC/CAS
219-371-7/2425-79-8
Name of the chemical
1,4-butanediol bis(2,3-epoxypropyl)ether
Concentration
1 - 25
General Information
Version
4.0
Revision date
2022-11-23
Product name
Alchemix EP 5242
1.2.1 Relevant identified uses
Industrial use,Professional use
Emergency telephone
+44 (0) 1926 641 600, +44 (0) 1872 572 377
Icons in SDS
Company Information
company name
Alchemie Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
sales@alchemie.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H318, H411
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP)]
Adverse physicochemical, human health and environmental effects
Causes skin irritation. May cause an allergic skin reaction. Causes serious eye damage. Toxic to aquatic life with long lasting effects.
2.2 Label elements
Labelling
Hazard pictograms
GHS05 GHS07 GHS09
Signal word
Danger
Contains
bis-[4-(2,3-epoxipropoxi)phenyl]propane, 1,4-bis(2,3 epoxypropoxy)butane; butanedioldiglycidyl ether
Hazard statements
H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H318 - Causes serious eye damage. H411 - Toxic to aquatic life with long lasting effects.
Precautionary statements
P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash hands thoroughly after handling. P280 - Wear eye protection, protective clothing, protective gloves. P305+P351+P338+P310 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER or doctor. P321 - Specific treatment (see supplemental first aid instruction on this label). P391 - Collect spillage.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII
